Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPermnt Tsb 30 Regulatory News (73HR)

Share Price Information for Permnt Tsb 30 (73HR)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
73HR Live PriceLast checked at - London Stock Exchange

Intraday Permnt Tsb 30 Share Chart

2016 Supervisory Review and Evaluation Process

13 Dec 2016 14:30

RNS Number : 7366R
Permanent TSB Group Holdings PLC
13 December 2016
Β 

13 December 2016

Β 

PERMANENT TSB GROUP HOLDINGS PLC

Β 

2016 Supervisory Review and Evaluation Process

Β 

Β 

The GroupΒ has been notified by the European Central Bank of the outcome of its 2016Β Supervisory Review and Evaluation ProcessΒ ("SREP") which will be effectiveΒ from 1 January 2017.

Β 

The decision requires that theΒ Group maintains a Common Equity Tier 1 ("CET 1") ratio ofΒ 9.2%Β and a Total Capital ratio of 12.7% until 31 December 2017Β on a transitional basis.

Β 

The CET 1Β ratio ofΒ 9.2% consists of a Pillar 1Β CapitalΒ RequirementsΒ RegulationΒ ("CRR")Β requirement ofΒ 4.50%, a Pillar 2 RequirementΒ ("P2R")Β ofΒ 3.45% and a Capital ConservationΒ BufferΒ ("CCB")Β of 1.25%.Β 

Β 

The Total Capital ratio of 12.7%Β consists of a Minimum Own FundsΒ CET1 requirement of 9.2% and a Minimum Own FundsΒ Tier 1 and Tier 2Β CRR requirementΒ ofΒ 3.5%.

Β 

Pillar 2 GuidanceΒ ("P2G")Β isΒ not publicly disclosed under the advice of the European Central Bank.

Β 

The 2016 SREP requirement compares to the Group'sΒ transitional CET1 ratio of 17.1% and a Total Capital ratio ofΒ 18.8% at 30 September 2016Β after adjusting for the effect of the sale of residual non-core UK assets completed in November 2016.

Β 

The Maximum Distributable Amount threshold has been set at 9.2%Β on a CET1 basis.

Β 

In addition, the 2016 SREP decision advises that the Group is prohibited from paying out dividends to shareholders.

Β 

Separately, the Group has recently been designated as an Other Systemically Important Institution ("O-SII") by the Central Bank of Ireland. As a result, the Group's capital requirement will increase by 0.25% in 2019 and 0.50% in 2020 to be held in the form of CET1 capital.

Β 

Both the SREP capital requirements (including the prohibition on payment of dividends) and O-SII buffers are subject to annual review.

Β 

Ends

Β 

For further information, please contact:

Β 

Patricia Carroll

Interim Group Chief Financial Officer

patricia.carroll@permanenttsb.ie

+353 1 669 5354

Rajesh ManirajanHead of Investor Relationsrajesh.manirajan@permanenttsb.ie+353 1 669 5622

Ray GordonGordon MRMptsb@gordonmrm.ie+353 87 241 7373

Β 

Β 

Note on forward-looking information:

This Announcement contains forward-looking statements, which are subject to risks and uncertainties because they relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Group or the industry in which it operates, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements referred to in this paragraph speak only as at the date of this Announcement. The Group undertakes no obligation to release publicly any revision or updates to these forward-looking statements to reflect future events, circumstances, unanticipated events, new information or otherwise except as required by law or by any appropriate regulatory authority.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRAKNDQBBDDNBD
Date   Source Headline
1st Mar 20237:00 amRNSCommentary on 2022 Annual Financial Report
1st Mar 20237:00 amRNSAnnual Financial Report
17th Jan 202310:00 amRNSAppointment of Board Chairperson Designate
11th Nov 20227:00 amRNSTrading Statement
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
21st Sep 20224:00 pmRNSSale of Buy To Let Portfolio
4th Aug 202210:00 amRNSDirectorate Change
27th Jul 20227:00 amRNSHalf-year Report
27th Jul 20227:00 amRNSCommentary on 2022 Half-Year Report
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
24th Jun 202212:40 pmRNSResult of EGM
24th Jun 202212:40 pmRNSResult of AGM
3rd May 20227:00 amRNSTrading Statement
31st Mar 20229:30 amRNSDirectorate Change
2nd Mar 20227:00 amRNSCommentary on 2021 Annual Financial Report
26th Jan 202212:00 pmRNSSuccession Plan for Board Chairman
17th Dec 20217:15 amRNSAcquisition of elements of Ulster Bank business
10th Nov 202110:00 amRNSSale of Loan Portfolio
28th Oct 20217:00 amRNSTrading Statement
28th Jul 20217:00 amRNSHalf-year Report
28th Jul 20217:00 amRNSCommentary on 2021 Half-Year Report
23rd Jul 20217:00 amRNSPotential acquisition: Certain Ulster Bank Assets
5th May 20217:00 amRNSTrading Statement
3rd Mar 20217:00 amRNSAnnual Financial Report
3rd Mar 20217:00 amRNSCommentary on 2020 Annual Financial Report
24th Feb 20217:00 amRNSRedemption of AT1 Securities
19th Feb 20217:05 amRNSStatement re: Ulster Bank Withdrawal from ROI
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
25th Sep 202010:00 amRNSAppointment of Interim CFO
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
26th Feb 20207:00 amRNSAnnual Financial Report
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
3rd Oct 201910:49 amBUSEarly Redemption(s)
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
27th Mar 20196:30 pmRNSAnnual Financial Report
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio
8th Nov 20187:00 amRNSTrading Statement
3rd Oct 201811:00 amRNSDirectorate Change
30th Aug 20188:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.